Michael Gelband’s Core Scientific CORZ Stock Holding History

Michael Gelband’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-57,484	Closed	-$860K	–	1642
2026 Q1	$860K	Sell	57,484 -357,333	-86%	-$6.09M	0.01%	1041
2025 Q4	$6.04M	Sell	414,817 -229,921	-36%	-$4.01M	0.05%	406
2025 Q3	$11.6M	Buy	644,738 +558,048	+644%	+$8.18M	0.12%	166
2025 Q2	$1.48M	Sell	86,690 -230,615	-73%	-$2.31M	0.01%	845
2025 Q1	$2.3M	Buy	+317,305	New	+$3.61M	0.02%	657
2024 Q4	–	Sell	-165,565	Closed	-$1.96M	–	1602
2024 Q3	$1.96M	Buy	165,565 +105,449	+175%	+$1.09M	0.01%	738
2024 Q2	$559K	Buy	+60,116	New	+$307K	﹤0.01%	1192

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Michael Gelband's CORZ Position: Q2 2026 in Review

Michael Gelband sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 57,484 shares — an estimated $860K sold.

Michael Gelband first reported a position in CORZ in Q2 2024 and held it in 7 quarters. The position peaked at $11.6M in Q3 2025. 411 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Michael Gelband reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 57,484 Core Scientific shares in Q2 2026, an estimated $860K.
Michael Gelband first reported a position in Core Scientific in Q2 2024 and held it in 7 quarters.
Michael Gelband's Core Scientific position peaked at $11.6M in Q3 2025.
411 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.